33500-88-8

Upstream product

• 4685-47-6 3,4-dimethylanisole 
• 22802-39-7 2-bromo-4,5-dimethylphenol 
• 77-78-1 dimethyl sulfate 
• 95-65-8 3,4-Dimethylphenol 

Downstream Products

• 854663-15-3 (2-methoxy-4,5-dimethyl-phenyl)-(2-methoxy-phenyl)-ether 
• 138042-06-5 2-methoxy-4,5-dimethylbenzanilide 
• 82544-94-3 N,N-diethyl-(2-methoxy-4,5-dimethyl)benzamide 
• 159847-55-9 N,N-dimethyl-2-methoxy-4,5-dimethylbenzamide 
• 159847-58-2 N-methyl-(2-methoxy-4,5-dimethyl)benzamide 
• 159847-56-0 N,N-dimethyl-(2-methoxy-4,5-dimethyl-6-prop-2'-enyl)benzamide 
• 1207065-35-7 1-bromo-4,5-bis(bromomethyl)-2-methoxybenzene 
• 1134082-52-2 2-(2-Methoxy-4,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 108123-09-7 (2-Methoxy-4,6-dimethyl-phenyl)-phenyl-sulfon 
• 2493-70-1 Phenyl-<2-hydroxy-4,5-dimethylphenyl>sulfon 
• 138042-05-4 N,N-diethyl-6-methoxy-3,4-dimethyl-2-trimethylsilylbenzamide 
• 138042-08-7 4,5-dihydro-2-(2'-methoxy-4',5'-dimethylphenyl)-4,4-dimethyloxazole 
• 138042-07-6 N-(2'-hydroxy-1',1'-dimethylethyl)-2-methoxy-4,5-dimethylbenzamide 
• 138042-04-3 1-(2-methoxy-4,5-dimethylphenyl)-2-methylbutan-1-one 

Relevant academic research and scientific papers

As neuroprotective agents of pharmaceutical compounds

The invention discloses a medicinal compound as a neuroprotective agent. The medicinal compound is a neuronal nitric oxide synthase-postsynaptic density protein 95 (nNOS-PSD95) decoupling agent. The medicinal compound is a benzene ring derivative shown in the general formula (I) or its pharmaceutically acceptable salt. The invention further discloses a preparation method of the medicinal compound and a use of the medicinal compound in prevention and treatment on neuronal damage influence-caused diseases.

The Stabilized Cation Pool Method: Metal- and Oxidant-Free Benzylic C-H/Aromatic C-H Cross-Coupling

Electrochemical oxidation of toluene derivatives in the presence of a sulfilimine gave benzylaminosulfonium ions as stabilized benzyl cation pools, which reacted with subsequently added aromatic nucleophiles to give the corresponding cross-coupling produc

Synthesis of the conformationally constrained tyrosine analogues, (R)- and (S)-5-hydroxy-2-aminoindan-2-carboxylic acids

(Chemical Equation Presented) The conformationally constrained tyrosine analogues, (R)- and (S)-5-hydroxy-2-aminoindan-2-carboxylic acids, were prepared by chromatographic separation of diastereomeric dipeptide derivatives formed from N-Boc-L-phenylalanin

METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY

Disclosed are compositions which modulate the interaction with nerve growth factor and precursors thereof with neurotrophic receptors. Also disclosed are methods of using the compositions of the invention, including methods of administration.